Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia

Cardiovascular Research

Volumn 71, Issue 1, 2006, Pages 179-188

  Barber, Melissa N ^a,b   Kanagasundaram, Meetali ^a   Anderson, Colin R ^a   Burrell, Louise M ^a   Woods, Robyn L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Animal model; Endothelial function; Intimal hyperplasia; Neutral endopeptidase; Vascular inflammation

Indexed keywords

ACETYLCHOLINE; CANDOXATRILAT; ENKEPHALINASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SILASTIC; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; AUTORADIOGRAPHY; CAROTID ARTERY; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISOTOPE LABELING; MACROPHAGE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; STATISTICAL SIGNIFICANCE; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AUTORADIOGRAPHY; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID STENOSIS; CYCLOHEXANECARBOXYLIC ACIDS; ENDOTHELIAL CELLS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MODELS, ANIMAL; NEPRILYSIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE INHIBITORS; RABBITS; TUNICA INTIMA; VASODILATOR AGENTS;

EID: 33744945013     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.03.019     Document Type: Article

References (43)

1. Wolinsky H. Insights into coronary angioplasty-induced restenosis from examination of atherogenesis. Am J Cardiol 60 (1987) 65B-67B
2. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
3. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
4. Li G., Chen S.J., Oparil S., Chen Y.F., and Thompson J.A. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101 (2000) 1362-1365
5. Hu Y., Zhang A., Torsney E., Afzal A.R., Davison F., Metzler B., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in apoe-deficient mice. J Clin Invest 113 (2004) 1258-1265
6. Barber M.N., Gaspari T., Kairuz E., Dusting G.J., and Woods R.L. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia. J Vasc Res 42 (2005) 101-110
7. Kairuz E.M., Barber M.N., Anderson C.R., Kanagasundaram M., Drummond G.R., and Woods R.L. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo. Cardiovasc Res 66 (2005) 574-582
8. Booth R.F., Martin J.F., Honey A.C., Hassall D.G., Beesley J.E., and Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 76 (1989) 257-268
9. Dusting G.J., Curcio A., Harris P.J., Lima B., Zambetis M., and Martin J.F. Supersensitivity to vasoconstrictor action of serotonin precedes the development of atheroma-like lesions in the rabbit. J Cardiovasc Pharmacol 16 (1990) 667-674
10. Johnson A.R., Ashton J., Schulz W.W., and Erdos E.G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 132 (1985) 564-568
11. Erdos E.G., and Skidgel R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3 (1989) 145-151
12. Soleilhac J.M., Lucas E., Beaumont A., Turcaud S., Michel J.B., Ficheux D., et al. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Mol Pharmacol 41 (1992) 609-614
13. Kugiyama K., Sugiyama S., Matsumura T., Ohta Y., Doi H., and Yasue H. Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11). Arterioscler Thromb Vasc Biol 16 (1996) 1080-1087
14. Roques B.P., Noble F., Dauge V., Fournie-Zaluski M.C., and Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45 (1993) 87-146
15. Kramer H.H., Schmidt K., Leis S., Schmelz M., Sommer C., and Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 195 (2005) 179-184
16. Danilewicz J.C., Barclay P.L., Barnish I.T., Brown D., Campbell S.F., James K., et al. Uk-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochem Biophys Res Commun 164 (1989) 58-65
17. Grantham J.A., Schirger J.A., Wennberg P.W., Sandberg S., Heublein D.M., Subkowski T., et al. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis. Circulation 101 (2000) 1976-1981
18. Kubota E., Dean R.G., Hubner R.A., Casley D.J., Johnston C.I., and Burrell L.M. Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in rat. Clin Sci (Lond) 105 (2003) 339-345
19. Kanazawa M., Casley D.J., Sybertz E.J., Haslanger M.F., and Johnston C.I. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor. J Pharmacol Exp Ther 261 (1992) 1231-1237
20. Gonzalez W., Soleilhac J.M., Fournie-Zaluski M.C., Roques B.P., and Michel J.B. Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels. Eur J Pharmacol 345 (1998) 323-331
21. De Meyer G.R., Van Put D.J., Kockx M.M., Van Schil P., Bosmans R., Bult H., et al. Possible mechanisms of collar-induced intimal thickening. Arterioscler Thromb Vasc Biol 17 (1997) 1924-1930
22. Tharaux P.L., Stefanski A., Ledoux S., Soleilhac J.M., Ardaillou R., and Dussaule J.C. EGF and TGF-beta regulate neutral endopeptidase expression in renal vascular smooth muscle cells. Am J Physiol 272 (1997) C1836-C1843
23. Topol E.J., and Serruys P.W. Frontiers in interventional cardiology. Circulation 98 (1998) 1802-1820
24. Lowe H.C., Oesterle S.N., and Khachigian L.M. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39 (2002) 183-193
25. Chen H.H., and Burnett Jr. J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 (1998) S22-S28
26. Marton Z., Pataricza J., Krassoi I., Varro A., and Papp J.G. NEP inhibitors enhance C-type natriuretic peptide-induced relaxation in porcine isolated coronary artery. Vasc Pharmacol 43 (2005) 207-212
27. Cahill P.A., and Hassid A. ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity. Am J Physiol 266 (1994) R194-R203
28. Brown J., and Chen Q. Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit. Circ Res 77 (1995) 906-918
29. Brown J., Chen Q., and Hong G. An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair. Am J Physiol 272 (1997) H2919-H2931
30. Qian J.Y., Haruno A., Asada Y., Nishida T., Saito Y., Matsuda T., et al. Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ Res 91 (2002) 1063-1069
31. Horio T., Kohno M., Kano H., Ikeda M., Yasunari K., Yokokawa K., et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. Circ Res 77 (1995) 660-664
32. Kano H., Kohno M., Yasunari K., Yokoyawa K., Horio T., Ikeda M., et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 14 (1996) 209-213
33. Sugano T., Tsuji H., Masuda H., Nishimura H., Yoshizumi M., Kawano H., et al. Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Arterioscler Thromb Vasc Biol 21 (2001) 1078-1083
34. Mathew V., Hasdai D., and Lerman A. The role of endothelin in coronary atherosclerosis. Mayo Clin Proc 71 (1996) 769-777
35. Loesch A., and Burnstock G. Ultrastructural localisation of serotonin and substance P in vascular endothelial cells of rat femoral and mesenteric arteries. Anat Embryol 178 (1988) 137-142
36. Farhy R.D., Ho K.L., Carretero O.A., and Scicli A.G. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 182 (1992) 283-288
37. Schirger J.A., Grantham J.A., Kullo I.J., Jougasaki M., Wennberg P.W., Chen H.H., et al. Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition. J Am Coll Cardiol 35 (2000) 796-801
38. Wollman Y., Blumberg S., Spungin A., Brenneman D.E., Fridkin M., Wollman J., et al. The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase. Regul Pept 108 (2002) 175-177
39. Ferro C.J., Spratt J.C., Haynes W.G., and Webb D.J. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation 97 (1998) 2323-2330
40. Doi K., Ikeda T., Itoh H., Ueyama K., Hosoda K., Ogawa Y., et al. C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol 21 (2001) 930-936
41. Turner A.J., Isaac R.E., and Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. BioEssays 23 (2001) 261-269
42. Ueno H., Haruno A., Morisaki N., Furuya M., Kangawa K., Takeshita A., et al. The local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation 96 (1997) 2272-2279
43. Morishige K., Shimokawa H., Yamawaki T., Miyata K., Eto Y., Kandabashi T., et al. Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodelling in porcine coronary arteries in vivo. J Am Coll Cardiol 35 (2000) 1040-1047